Literature DB >> 20590892

Prognostic scores for colorectal liver metastasis: clinically important or an academic exercise?

Dhanwant Gomez1, Iain C Cameron.   

Abstract

OBJECTIVES: Over the last decade, various groups have proposed prognostic scoring systems for patients with colorectal liver metastasis (CLM) treated with hepatic resection. The aims of the current study were to evaluate the differences between and clinical importance of these prognostic scoring systems and to determine their clinical applicability.
METHODS: Relevant articles were reviewed from the published literature using the MEDLINE database. The search was performed using the keywords 'colorectal cancer', 'metastases', 'liver resection' and 'hepatectomy'.
RESULTS: Twelve prognostic scoring systems were identified from 1996 to 2009. Six of these originated from European institutions, three from Asian and three from North American centres. The median study sample was 288 patients (range 81-1568 patients) and median follow-up was 35 months (range 16-52 months). All studies were retrospective in nature and the numbers of groups proposed by the various scoring systems ranged from three to six. All the studies used the Cox proportional hazard model for multi-variable analysis.
CONCLUSIONS: There is no 'ideal' prognostic scoring system for the clinical management of patients with CLM for hepatic resection. These prognostic scoring systems are clinically relevant with respect to survival but have not been used for risk stratification in controversial areas such as the administration of chemotherapy or surveillance programmes.

Entities:  

Mesh:

Year:  2010        PMID: 20590892      PMCID: PMC2873645          DOI: 10.1111/j.1477-2574.2010.00158.x

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN: 1365-182X            Impact factor:   3.647


  57 in total

Review 1.  A review of techniques for liver resection.

Authors:  A G Heriot; N D Karanjia
Journal:  Ann R Coll Surg Engl       Date:  2002-11       Impact factor: 1.891

2.  Guidelines for resection of colorectal cancer liver metastases.

Authors:  O J Garden; M Rees; G J Poston; D Mirza; M Saunders; J Ledermann; J N Primrose; R W Parks
Journal:  Gut       Date:  2006-08       Impact factor: 23.059

3.  The impact of margins on outcome after hepatic resection for colorectal metastasis.

Authors:  Chandrakanth Are; Mithat Gonen; Kathleen Zazzali; Ronald P Dematteo; William R Jarnagin; Yuman Fong; Leslie H Blumgart; Michael D'Angelica
Journal:  Ann Surg       Date:  2007-08       Impact factor: 12.969

4.  Effect of subcentimeter nonpositive resection margin on hepatic recurrence in patients undergoing hepatectomy for colorectal liver metastases. Evidences from 663 liver resections.

Authors:  J Figueras; F Burdio; E Ramos; J Torras; L Llado; S Lopez-Ben; A Codina-Barreras; S Mojal
Journal:  Ann Oncol       Date:  2007-04-13       Impact factor: 32.976

5.  Hepatic resection for colorectal liver metastases: A cost-effectiveness analysis.

Authors:  S M Beard; M Holmes; C Price; A W Majeed
Journal:  Ann Surg       Date:  2000-12       Impact factor: 12.969

6.  Utility of FDG-PET for investigating unexplained plasma CEA elevation in patients with colorectal cancer.

Authors:  F L Flanagan; F Dehdashti; O A Ogunbiyi; I J Kodner; B A Siegel
Journal:  Ann Surg       Date:  1998-03       Impact factor: 12.969

7.  Effect of preoperative chemotherapy on liver resection for colorectal liver metastases.

Authors:  N N Mehta; R Ravikumar; C A Coldham; J A C Buckels; S G Hubscher; S R Bramhall; S J Wigmore; A D Mayer; D F Mirza
Journal:  Eur J Surg Oncol       Date:  2007-12-21       Impact factor: 4.424

8.  Repeat hepatic resections for metastatic colorectal cancer.

Authors:  Y Fong; L H Blumgart; A Cohen; J Fortner; M F Brennan
Journal:  Ann Surg       Date:  1994-11       Impact factor: 12.969

9.  Actual 10-year survival after resection of colorectal liver metastases defines cure.

Authors:  James S Tomlinson; William R Jarnagin; Ronald P DeMatteo; Yuman Fong; Peter Kornprat; Mithat Gonen; Nancy Kemeny; Murray F Brennan; Leslie H Blumgart; Michael D'Angelica
Journal:  J Clin Oncol       Date:  2007-10-10       Impact factor: 44.544

10.  Preoperative prognostic score for predicting survival after hepatic resection for colorectal liver metastases.

Authors:  Hassan Z Malik; K Rajendra Prasad; Karim J Halazun; Amir Aldoori; Ahmed Al-Mukhtar; Dhanwant Gomez; J Peter A Lodge; Giles J Toogood
Journal:  Ann Surg       Date:  2007-11       Impact factor: 12.969

View more
  22 in total

1.  Identification of patients likely to benefit from metastasectomy in stage IV colorectal cancer.

Authors:  Manabu Shimomura; Masazumi Okajima; Takao Hinoi; Hiroyuki Egi; Yuji Takakura; Yasuo Kawaguchi; Masakazu Tokunaga; Tomohiro Adachi; Hirotaka Tashiro; Hideki Ohdan
Journal:  Int J Colorectal Dis       Date:  2012-03-10       Impact factor: 2.571

2.  Primary lymph node ratio and hepatic resection for colorectal metastases.

Authors:  Daniel Ansari; William Torén; Roland Andersson
Journal:  Hepatobiliary Surg Nutr       Date:  2018-04       Impact factor: 7.293

3.  Management of potentially resectable colorectal cancer liver metastases.

Authors:  Fausto Meriggi; Paola Bertocchi; Alberto Zaniboni
Journal:  World J Gastrointest Surg       Date:  2013-05-27

Review 4.  Adjuvant chemotherapy for resected colorectal cancer metastases: Literature review and meta-analysis.

Authors:  Giovanni Brandi; Stefania De Lorenzo; Margherita Nannini; Stefania Curti; Marta Ottone; Filippo Gustavo Dall'Olio; Maria Aurelia Barbera; Maria Abbondanza Pantaleo; Guido Biasco
Journal:  World J Gastroenterol       Date:  2016-01-14       Impact factor: 5.742

5.  Genetic And Morphological Evaluation (GAME) score for patients with colorectal liver metastases.

Authors:  G A Margonis; K Sasaki; S Gholami; Y Kim; N Andreatos; N Rezaee; A Deshwar; S Buettner; P J Allen; T P Kingham; T M Pawlik; J He; J L Cameron; W R Jarnagin; C L Wolfgang; M I D'Angelica; M J Weiss
Journal:  Br J Surg       Date:  2018-04-25       Impact factor: 6.939

6.  The influence of desmocollin 1-3 expression on prognosis after curative resection of colorectal liver metastases.

Authors:  Silke Schüle; Claudia Neuhäuser; Falk Rauchfuß; Thomas Knösel; Utz Settmacher; Annelore Altendorf-Hofmann
Journal:  Int J Colorectal Dis       Date:  2013-08-24       Impact factor: 2.571

7.  Combined cerebral and somatic near-infrared spectroscopy oximetry monitoring during liver surgery: an observational and non-interventional study.

Authors:  Yves Collin; Tina Hu; André Denault; Annik Fortier; William Beaubien-Souligny; Réal Lapointe; Franck Vandenbroucke-Menu
Journal:  Korean J Anesthesiol       Date:  2022-01-20

Review 8.  Molecular Determinants and Other Factors to Guide Selection of Patients for Hepatic Resection of Metastatic Colorectal Cancer.

Authors:  Thomas M Diehl; Daniel E Abbott
Journal:  Curr Treat Options Oncol       Date:  2021-07-05

9.  Effect of neoadjuvant chemotherapy in patients with resectable colorectal liver metastases.

Authors:  Dexiang Zhu; Yunshi Zhong; Ye Wei; Lechi Ye; Qi Lin; Li Ren; Qinghai Ye; Tianshu Liu; Jianmin Xu; Xinyu Qin
Journal:  PLoS One       Date:  2014-01-21       Impact factor: 3.240

10.  Novel methods for clinical risk stratification in patients with colorectal liver metastases.

Authors:  Ki-Yeol Kim; Nam Kyu Kim; In-Ho Cha; Joong Bae Ahn; Jin Sub Choi; Gi-Hong Choi; Joon Suk Lim; Kang Young Lee; Seung Hyuk Baik; Byung Soh Min; Hyuk Hur; Jae Kyung Roh; Sang Joon Shin
Journal:  Cancer Res Treat       Date:  2014-09-11       Impact factor: 4.679

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.